Username Password
S&P 500: 1,317.11 Change: -0.21%
Neurodoc
P&P Score: 99.39   Points: 88.35   Accuracy: 47.75%   Average Pick Score: 0.31   Annual Return: 10.03% (36.16% since 10/18/08)  

Neurodoc's Blog : BDX, FDI and ovarian cancer screen

Date May 22, 2010    Comments Comments (0)    Rate this post Recommend This Post (84)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This
I saw an AP news article and then found a news release on what appears to be a potentially valuable screen for ovarian cancer, currently difficult to diagnose in early stages. If further studies pan out, I suspect screening for ovarian cancer in women will mirror current PSA screening in men for prostate cancer. It appears FDI (Fujirebio) is not a publicly traded company but is partnering with Becton Dickinson (BDX) which is. Here is a news release:

http://www.fdi.com/documents/news/050409.pdf
Tags : BDX  

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links